Article Details
Retrieved on: 2025-04-12 12:42:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
COSCIENS Biopharma ( TSE:CSCI ) Full Year 2024 Results Key Financial Results Revenue: US$9.59m (up 113% from FY 2023...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here